3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Multiple Myeloma
2
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Mesothelioma, Malignant
1
Melanoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Carcinoma, Squamous Cell
1
Interventions
pegaspargase
5
tislelizumab
2
selinexor
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
Asparaginase
2
sugemalimab
1
relatlimab
1
pembrolizumab
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
Vorinostat
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
In Situ Hybridization, Fluorescence
×
1 year
×
Clear all
No trials found.